Non-Current Assets

Other intangible assets—net

West Pharmaceutical Services Other intangible assets—net decreased by 9.1% to $7.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 30.0%, from $10.00M to $7.00M. Over 5 years (FY 2020 to FY 2025), Other intangible assets—net shows a downward trend with a -24.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryMarket Position
SignalHigher is better
VolatilityStable
First reportedQ4 2015
Last reportedQ1 2026

How to read this metric

An increase typically signals recent strategic acquisitions or significant investment in R&D and intellectual property, while a decrease reflects ongoing amortization or potential impairment.

Detailed definition

This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software...

Peer comparison

High in semiconductor and tech firms due to heavy reliance on patent portfolios and acquired technology.

Metric ID: non_current_assets_intangible_assets_net_excluding_goodwill

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$27.80M$26.10M$23.00M$21.80M$20.00M$18.10M$18.40M$17.80M$16.80M$15.70M$15.10M$13.90M$12.90M$12.30M$10.80M$10.00M$9.70M$8.90M$7.70M$7.00M
QoQ Change-6.1%-11.9%-5.2%-8.3%-9.5%+1.7%-3.3%-5.6%-6.5%-3.8%-7.9%-7.2%-4.7%-12.2%-7.4%-3.0%-8.2%-13.5%-9.1%
YoY Change-28.1%-30.7%-20.0%-18.3%-16.0%-13.3%-17.9%-21.9%-23.2%-21.7%-28.5%-28.1%-24.8%-27.6%-28.7%-30.0%
Range$7.00M$27.80M
CAGR-25.2%
Avg YoY Growth-23.7%
Median YoY Growth-24.0%
Current Streak13 quarters decline

Frequently Asked Questions

What is West Pharmaceutical Services's other intangible assets—net?
West Pharmaceutical Services (WST) reported other intangible assets—net of $7.00M in Q1 2026.
How has West Pharmaceutical Services's other intangible assets—net changed year-over-year?
West Pharmaceutical Services's other intangible assets—net decreased by 30.0% year-over-year, from $10.00M to $7.00M.
What is the long-term trend for West Pharmaceutical Services's other intangible assets—net?
Over 5 years (2020 to 2025), West Pharmaceutical Services's other intangible assets—net has grown at a -24.1% compound annual growth rate (CAGR), from $30.50M to $7.70M.
What does other intangible assets—net mean?
The value of non-physical assets like patents and intellectual property, excluding goodwill.